ROCHE HOLDING AG |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 245 EUR | -0.08% |
|
-2.62% | +15.68% |
| 31/05 | ROCHE HOLDINGS AG : Gets a Neutral rating from UBS | ZD |
| 31/05 | Transcript : Roche Holding AG - Shareholder/Analyst Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 734B | ||||||
| 591B | ||||||
| 350B | ||||||
| 315B | ||||||
| 276B |
